A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Conditions
Metastatic Castration Resistant Prostate Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
GenesisCare North Shore (Oncology), Sydney, New South Wales, Australia
Contact: Principal Investigator (Ganessan Kichenadasse)Sydney Adventist Hospital, Sydney, New South Wales, Australia
Contact: Principal Investigator (Gavin Marx, Prof)Cancer Research SA, Adelaide, South Australia, Australia
Contact: Study coordinator (Sarwan Bishnoi)Contact: Principal Investigator (Sarwan Bishnoi)Southern Oncology Clinical Research Unit, Adelaide, South Australia, Australia
Contact: Principal Investigator (Ganessan Kichenadasse)Icon Cancer Centre South Brisbane, Brisbane, Australia
Contact: Principal Investigator (Jermaine Coward, Dr)John Flynn Private Hospital, Brisbane, Australia
Contact: Principal Investigator (David Martin, Dr)Eastern Health (Box Hill Hospital), Melbourne, Australia
Contact: Principal Investigator (Ian Davis)Linear Clinical Research Ltd, Perth, Australia
Contact: Principal Investigator (Timothy Humphries, Dr)Macquarie University, Sydney, Australia
Contact: Principal Investigator (Howard Gurney)MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy, Sydney, Australia
Contact: Study coordinator (Jane Stidworthy)Contact: Principal Investigator (Howard Gurney)Illawarra Shoalhaven Local Health District (Wollongong Hospital), Wollongong, Australia
Contact: Principal Investigator (Gary Tincknell, Dr)